Advertisement
Advertisement

GNPX

GNPX logo

Genprex Inc

0.8248
USD
-0.1952
-19.14%
Dec 18, 15:52 UTC -5
Closed
...

Genprex Inc Profile

About

Genprex Inc. operates as a biotechnology company. It discovers and develops immunogene therapies for cancer treatment as well as clinical research, gene therapies, consulting and other related medical services. The company's initial product candidate is Oncoprex(TM) immunogene therapy which treats non-small cell lung cancer. Genprex Inc. is based in United States.

Info & Links

CEO

J. Rodney Varner

Headquarters

3300 Bee Cave Road, #650-227,
AUSTIN, TX 78746, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.genprex.com

Auditor

WithumSmith+Brown, PC

Share holders

158

Employees

26

Genprex Inc Statistics

Valuation Measures

Market Capitalization2

7.02M

Enterprise Value

5.53M

Enterprise Value/EBITDA(ttm)

-0.25

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.82

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-409.48%

Return on Invested Capital(ttm)

-556.82%

Return on Assets(ttm)

-269.17%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-22.04M

Net Income Available to Common(ttm)

-22.71M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-1.38

52-Week Change

-91.44%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

8.51M

Dividend Yield

0.00%

Float4

7.79M

% Held by Insiders

8.47%

% Held by Institutions

14.05%

Balance Sheet

Total Cash(mrq)

1.49M

Total Cash Per Share(mrq)

0.17

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.86%

Quick Ratio(mrq)

0.86%

Book Value Per Share(mrq)

0.30

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.79

Free Cash Flow(ytd)

-13.28M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement